MARKET

RVPH

RVPH

Reviva Pharmaceutcls Hldgs Inc
NASDAQ
2.470
-0.180
-6.79%
Pre Market: 2.560 +0.09 +3.64% 05:04 03/16 EDT
OPEN
2.680
PREV CLOSE
2.650
HIGH
2.680
LOW
2.370
VOLUME
632
TURNOVER
0
52 WEEK HIGH
24.50
52 WEEK LOW
2.370
MARKET CAP
14.43M
P/E (TTM)
-0.2615
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RVPH last week (0309-0313)?
Weekly Report · 7h ago
Weekly Report: what happened at RVPH last week (0302-0306)?
Weekly Report · 03/09 10:08
Upcoming Stock Splits This Week (March 9 to March 13) – Stay Invested
TipRanks · 03/08 15:35
NASDAQ TRADE HALT CONTINUES <RVPH.O> HALT NEWS PENDING AT 03:28 AM
Reuters · 03/08 07:28
Reviva Pharmaceuticals Holdings trading halted, news pending
TipRanks · 03/07 00:50
Analysts Offer Insights on Healthcare Companies: ArriVent BioPharma, Inc. (AVBP), Chemomab Therapeutics (CMMB) and Reviva Pharmaceuticals Holdings (RVPH)
TipRanks · 03/06 13:20
Reviva Pharm Holdings Cut to Hold From Buy by D. Boral Capital
Dow Jones · 03/05 21:49
D. Boral Capital Downgrades Reviva Pharmaceuticals to Hold
Benzinga · 03/05 21:39
More
About RVPH
Reviva Pharmaceuticals Holdings, Inc. is a late-stage pharmaceutical company. The Company discovers, develops, and seeks to commercialize therapeutics for diseases representing unmet medical needs. The Company’s pipeline focuses on the central nervous system, inflammatory, and cardiometabolic diseases. Its pipeline includes two drug candidates, brilaroxazine (RP5063) and RP1208. Its lead drug candidate, brilaroxazine, is in clinical development and is to treat multiple neuropsychiatric indications. These include schizophrenia, bipolar disorder (BD), major depressive disorder (MDD), attention-deficit/hyperactivity disorder (ADHD), behavioral and psychotic symptoms of dementia or Alzheimer’s disease (BPSD), and Parkinson’s disease psychosis. Brilaroxazine is also ready for clinical development for two respiratory indications, including pulmonary arterial hypertension (PAH) and idiopathic pulmonary fibrosis (IPF). Its RP1208 drug candidate is a triple reuptake inhibitor (TRI).

Webull offers Reviva Pharmaceuticals Holdings Inc stock information, including NASDAQ: RVPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RVPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RVPH stock methods without spending real money on the virtual paper trading platform.